Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Brodsky, Alexander S ^a,b,c   Fischer, Andrew ^a   Miller, Daniel H ^a   Vang, Souriya ^a   MacLaughlan, Shannon ^b,h   Wu, Hsin Ta ^a,b,d   Yu, Jovian ^b   Steinhoff, Margaret ^b   Collins, Colin ^e   Smith, Peter J S ^f   Raphael, Benjamin J ^b,d   Brard, Laurent ^g  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d Brown Univerity   (United States)

^e VANCOUVER PROSTATE CENTRE   (Canada)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; COPY NUMBER VARIATION; CYTOREDUCTIVE SURGERY; DISEASE ACTIVITY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; OMENTUM; OVARY CARCINOMA; OVERALL SURVIVAL; PERITONEUM METASTASIS; PHENOTYPE; PRIMARY TUMOR; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VALIDATION PROCESS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; OVARY TUMOR; PATHOLOGY; TUMOR GENE;

APOPTOSIS; CELL PROLIFERATION; CLUSTER ANALYSIS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; NEOPLASM METASTASIS; OMENTUM; OVARIAN NEOPLASMS; PHENOTYPE; RNA, MESSENGER;

EID: 84899635321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094476     Document Type: Article

References (38)

1. Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177: 1053-1064. doi:10.2353/ajpath.2010.100105.
2. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009. doi:10.1038/nature08021.
3. Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, et al. (2006) Genomic profiling of hormone-naive lymph node metastases in patients with prostate cancer. Neoplasia 8: 1083-1089. doi:10.1593/neo.06421. (Pubitemid 44936158)
4. Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, et al. (2004) Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 90: 686-692. doi:10.1038/sj.bjc.6601603. (Pubitemid 38297211)
5. Hibbs K, Skubitz KM, Pambuccian SE, Casey RC, Burleson KM, et al. (2004) Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 165: 397-414. doi:10.1016/S0002-9440(10)63306-8. (Pubitemid 38971371)
6. Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, et al. (2006) Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer 16: 1733-1745. doi:10.1111/j.1525-1438.2006.00660.x. (Pubitemid 44470029)
7. Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, et al. (2008) Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer research 68: 4606-4613. doi:10.1158/0008-5472.CAN-07-5046.
8. Moss NM, Barbolina MV, Liu Y, Sun L, Munshi HG, et al. (2009) Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer research 69: 7121-7129. doi:10.1158/0008-5472.CAN-08-4151.
9. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, et al. (2008) Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer research 68: 2329-2339. doi:10.1158/0008-5472.CAN- 07-5167. (Pubitemid 351521807)
10. Padua D, Massague J (2009) Roles of TGFbeta in metastasis. Cell Res 19: 89-102. doi:10.1038/cr.2008.316.
11. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, et al. (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461: 809-813. doi:10.1038/nature08489.
12. Yamamura S, Matsumura N, Mandai M, Huang Z, Oura T, et al. (2012) The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int J Cancer 130: 20-28. doi:10.1002/ijc.25961.
13. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117. doi:10.1038/nature09515.
14. Venkatraman ES, Olshen AB (2007) A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics (Oxford, England) 23: 657-663. doi:10.1093/bioinformatics/btl646. (Pubitemid 46554715)
15. GENE-E software website. Available: http://www.broadinstitute.org/cancer/ software/GENE-E/index.html. Accessed 2014 Mar 18.
16. Malek JA, Martinez A, Mery E, Ferron G, Huang R, et al. (2012) Gene expression analysis of matched ovarian primary tumors and peritoneal metastasis. J Transl Med 10: 121. doi:10.1186/1479-5876-10-121.
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550. (Pubitemid 41528093)
18. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, et al. (2007) The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183. doi:10.1186/gb-2007-8-9-r183. (Pubitemid 351895482)
19. Bitler BG, Nicodemus JP, Li H, Cai Q, Wu H, et al. (2011) Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence. Cancer research. doi:10.1158/0008-5472.CAN-11-1341.
20. Burkhalter RJ, Symowicz J, Hudson LG, Gottardi CJ, Stack MS (2011) Integrin regulation of beta-catenin signaling in ovarian carcinoma. J Biol Chem 286: 23467-23475. doi:10.1074/jbc.M110.199539.
21. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54. doi:10.1038/ng1060. (Pubitemid 36068681)
22. Kang J, D'Andrea AD, Kozono D (2012) A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. J Natl Cancer Inst 104: 670-681. doi:10.1093/jnci/djs177.
23. Khalique L, Ayhan A, Whittaker JC, Singh N, Jacobs IJ, et al. (2009) The clonal evolution of metastases from primary serous epithelial ovarian cancers. Int J Cancer 124: 1579-1586. doi:10.1002/ijc.24148.
24. Tothill RW, Tinker AV, George J, Brown R, Fox SB, et al. (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14: 5198-5208. doi:10.1158/1078-0432.CCR-08-0196.
25. Wimberger P, Wehling M, Lehmann N, Kimmig R, Schmalfeldt B, et al. (2010) Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group). Ann Surg Oncol 17: 1642-1648. doi:10.1245/s10434-010-0964-9.
26. Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, et al. (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170: 974-9-discussion979-80.
27. Venet D, Dumont JE, Detours V (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240. doi:10.1371/journal.pcbi.1002240.
28. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949. doi:10.1038/nm1093. (Pubitemid 39273735)
29. Barnett JC, Bean SM, Whitaker RS, Kondoh E, Baba T, et al. (2010) Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Gynecologic oncology 116: 556-562. doi:10.1016/j.ygyno. 2009.11.020.
30. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, et al. (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102: 18538-18543. doi:10.1073/pnas.0509182102. (Pubitemid 43011261)
31. Derycke MS, Charbonneau B, Preston CC, Kalli KR, Knutson KL, et al. (2013) Toward understanding the genetics of regulatory T cells in ovarian cancer. Oncoimmunology 2: e24535. doi:10.4161/onci.24535.
32. Bashashati A, Ha G, Tone A, Ding J, Prentice LM, et al. (2013) Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol 231: 21-34. doi:10.1002/path. 4230.
33. Gorringe KL, George J, Anglesio MS, Ramakrishna M, Etemadmoghadam D, et al. (2010) Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. PLoS ONE 5. doi:10.1371/journal.pone.0011408.
34. Tuefferd M, Couturier J, Penault-Llorca F, Vincent-Salomon A, Broet P, et al. (2007) HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients. PLoS ONE 2: e1138. doi:10.1371/journal.pone.0001138. (Pubitemid 351597374)
35. Bronson MW, Hillenmeyer S, Park RW, Brodsky AS (2010) Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells. Mol Endocrinol 24: 1120-1135. doi:10.1210/me.2009-0436.
36. Fernald K, Kurokawa M (2013) Evading apoptosis in cancer. Trends Cell Biol. doi:10.1016/j.tcb.2013.07.006.
37. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, et al. (2010) Ligandindependent activation of c-Met by fibronectin and alpha(5)beta(1)- integrin regulates ovarian cancer invasion and metastasis. Oncogene. doi:10.1038/onc.2010.532.
38. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, et al. (2002) Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 13: 1977-2000. doi:10.1091/mbc.02-02-0030. (Pubitemid 34651487)